A Neurosurgical Aspirin Intervention Study
Recruiting
- Conditions
- Post-operative hemorrhagic complications and thrombo-embolic complications after neurosurgical spinal surgeries in patients using aspirin anti-thrombotic medication.
- Registration Number
- NL-OMON20747
- Lead Sponsor
- Haaglanden medical center.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 554
Inclusion Criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•Scheduled spinal surgery
•Preoperative use of aspirin
•Age >18
Exclusion Criteria
A potential subject who meets any of the following criteria will be excluded from participation in this study:
•Surgery with high risk for hemorrhage such as tumors requiring preoperative embolization
•Staged surgeries lasting more than one day
•Patients with a pre-existing coagulopathy
•Patients using antithrombotic drugs or other platelet aggregation inhibitors than aspirin
•Patients with absolute contraindication for discontinuing aspirin (e.g. coronary stenting within 1 year)
•Patients aged under 18
•Emergency surgical procedures
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primay outcome measures include perioperative blood loss, hemorrhage related complications and need for reoperation.
- Secondary Outcome Measures
Name Time Method Secondary outcome is the reduction of cardiac and neurologic thrombotic perioperative events within 30 days after surgery.